A Cannabis public stock is one of the possible prospects for a cannabis company. Stocks can be sold in the open market and traded on an exchange to raise capital for new businesses. Some companies will list their shares in exchange for equity or debt. These stocks enable investors to invest indirectly in the cannabis industry by purchasing stock traded on any major U.S. Exchange, like Nasdaq or NYSE. Let’s look at the 9 best cannabis public stocks of 2023 with huge potential and where you can get huge returns from investing now!
How To Invest In Cannabis Stocks?
There are two ways to invest in cannabis public stocks. The first is to invest in the stock of a cannabis company that grows, distributes, and sells it. The second way is to purchase the stocks of an established publicly-traded company that has indirect exposure to the cannabis industry; these are called “ancillary plays.” A good example is Charlotte’s Web Holdings (CWEB), which owns a hemp farm, making it an indirect player, or Innovative Industrial Properties Inc (IIPR), which leases warehouse space to growers but doesn’t grow or distribute marijuana products.
What Are The Risks Of Investing In Cannabis Public Stocks?
The biggest risk that comes with investing in cannabis public stocks is the fact that the business is still illegal on the federal level. This means that it is highly unlikely for a publicly traded cannabis company to obtain financial services from a bank with locations across the country. It also means most credit card companies will not allow the use of their cards to purchase cannabis products. Even though Congress has passed legislation to allow states to create laws regarding marijuana, it’s likely not going to change anytime soon. This could be bad news for public companies in a rapidly growing industry, as 29 states have legalized medical marijuana, and eight states have laws making recreational marijuana legal.
What Is A Good Cannabis Public Stocks To Buy Now?
Though it may seem like marijuana is legal in an increasing number of states, for now at least, the federal government still sees it as a Schedule I drug, which makes growing it and selling it even in legal states perilous. That said, there are ways to invest indirectly in the cannabis industry. The most direct way is buying shares in a cannabis public stocks company. If you want to invest directly, you will have to wait until marijuana becomes either federally legal or at least decriminalized before we see public companies with access to traditional banking and capital markets. So that leaves us with the second option, ancillary plays. This type of play is one where you invest in a publicly traded company with indirect exposure to the cannabis industry. Since we don’t have access to banks, credit cards, or traditional capital markets, we must be content with our options.
Which Make A Good Investment In Cannabis Public Stocks?
There are several good cannabis stocks out there. Some may not be the best direct investments but could be great candidates for ancillary plays. Any way you look at it, it remains to be seen just how big this industry could be in the long run and which companies will come out on top. Where do you go to find the best cannabis stocks? We often turn to analysts at the big brokerage firms who compile lists of stocks they think will perform well and make recommendations on which cannabis companies are worth watching. For your reading pleasure, we present our list of the 9 best cannabis public stocks of 2023.
9 Best Cannabis Public Stocks Of 2023:
1. United Cannabis Corporation (CNAB):
United Cannabis Corporation (CNAB) is a leading diversified cannabis company committed to providing the highest quality and most innovative products. CNAB serves its customers by delivering products that meet the highest quality, consistency, and potency standards, setting the industry standard for organic cannabis. CNAB also provides a full suite of CBD-based products under its proprietary Good+ product line, which leverages CBD’s benefits for skin health, wellness, and vitality. Its product portfolio includes low-, mid-, and high-dose vaporizer cartridges; sublingual sprays; tinctures; edibles; topicals; capsules, and beverages.
2. Cannabis Sativa, Inc. (CBDS):
Cannabis Sativa, Inc. is one of the first publicly traded cannabis stocks and has provided quality products to the cannabis industry since 2009. The Company currently operates in 3 distinct areas, including wholesale and retail sales of raw material (including biomass and plant materials), as well as manufacturing of a line of consumer packaged goods (“CPG”) branded products focusing on vaporous products and topical applications. Its consumer brands include “HempMeds®” for specialty market distribution in the natural channel and licensing agreements for other branded consumer products under the “CBDS®” label.
3. Global Cannabis Applications Corp (GLH):
Global Cannabis Applications Corp is a North America-focused cannabis company focusing on the wholesale supply of bulk hemp stalk and CBD oil to larger companies that formulate their products. The Company has partnered with many large companies, including Canopy Growth Corp (WEED.TO) and Organigram Holdings Inc OGI.V), to source their hemp from the Company’s farms in Kentucky and Colorado. GLH also operates hemp farms in Nevada and New York and will continue to look for additional states to enter into production agreements for bulk supply contracts. As public acceptance of the cannabis industry grows, the potential for GLH to profit from its supply agreements with larger manufacturers could be quite significant. Recently, GLH announced that it is set to become a distributor of medical cannabis products under Health Canada regulations when it obtains a license amendment.
4. GW Pharmaceuticals PLC- ADR (GWPH):
GW Pharmaceuticals plc engages in discovering and developing cannabinoid prescription medicines using botanical extracts derived from the cannabis plant. Its lead product candidate is Epidiolex which has completed Phase III trials for treating seizures associated with two rare and severe forms of epilepsy, Lennox-Gastaut syndrome (LGS) and Dravet syndrome. The Company’s other product candidate is Sativex for treating spasticity due to multiple sclerosis. GW Pharmaceuticals has a research collaboration and license agreement with Otsuka Pharmaceutical Co Ltd to develop cannabinoid prescription medicines. Its product pipeline also includes Epidiolex.
5. Cannabis Science, Inc (CBIS):
Cannabis Science, Inc., through its subsidiaries, develops and commercializes science-based cannabinoid therapeutics to meet global needs. Its products include Real Scientific Hemp Oil or RH. The Company offers cannabis and hemp-derived therapeutic products, including CannaStrips, a CBD product designed to treat opioid addiction; CannaTreats with nano-emulsified THC; CanChew with nano-emulsified cannabidiol; and CanChew+ with nano-emulsified THC and CBD. The Company serves customers in primary healthcare settings and pharmaceutical sales channels.
6. MedMen Enterprises Inc (MMNFF):
MedMen was founded in 2010 and officially opened its first marijuana dispensary in West Hollywood, CA, on July 1st, 2018. The Company’s dispensaries provide an “environment-friendly approach to medical cannabis, whereby all products are pesticide-free, cultivated in an eco-conscious manner, and delivered to the patient in various strengths and preparations.” MedMen is also known for its state-of-the-art cultivation facilities and award-winning genetics. The Company is also actively expanding its business into ancillary areas, such as producing cannabis concentrates, edibles, and infused beverages. MedMen has eight store locations in California, including Hollywood, Santa Ana, Venice Beach, Downtown Los Angeles, Marina Del Rey, and San Diego, and three are coming soon in San Francisco.
7. Hemp, Inc. (HEMP)
Hemp, Inc. engages in the business of licensing industrial hemp cultivars and broad-based U.S. CBD extracts for the production of hemp products. Hemp, Inc. also provides developing and integrates commercial scale extraction and manufacturing systems for CBD oils. The Company is also engaged in acquiring and licensing industrial hemp cultivars and broad-based U.S. CBD extracts for producing hemp products. Further, the Company seeks to establish and enhance the infrastructure for its products’ research, development, and production. Hemp, Inc. was formerly known as Hemp Wealth Media, Inc.
8. Vape Holdings Inc (VAPE):
Vape Holdings Inc designs, develops, and markets vaporizers, liquids, and other branded products across North America. The Company aims to be the market leader in delivering various products with unparalleled levels of customer service and support to its customers while achieving profitability through ongoing development efforts that focus on quality product innovation and branding strategies. Its product offerings include Liberty™ Vaporizer, Royal 31™ Vaporizer, Royal Canna™, Royal Treatment™, and Silla™. The Company serves customers by demand placing into major supermarkets and pharmacies in both Canada and the United States of America.
9. Green Growth Brands Inc (GNWTF):
Green Growth Brands Inc engages in the development of a branded cannabis lifestyle brand in the U.S. Its lifestyle brands include Chakra, a drive-thru medical and recreational cannabis dispensary in Santa Ana, California, with over 400 employees and an additional 30 dispensaries throughout California, Nevada, Oregon, and Washington. The Company is also the franchisor of the Chakra retail stores concepts Wicked Wich® Sandwiches and West Coast Caregivers®, providing a broad selection of products available through medical marijuana dispensaries. Green Growth Brands uses technology-based social media marketing tools to increase brand awareness. It also develops a range of marketing campaigns to build business goodwill in attractive markets with a high potential for return on investment.
Conclusion
As the cannabis industry takes off and Canada fully legalizes cannabis for adult use later this year, investors will look for investments in this growing sector. There are plenty of Canadian-based cannabis companies that can lead to exceptional returns in 2018, but a few of them, which are listed above, are good options to keep an eye on. Each Company listed above offers plenty of upside potential and some downside protection which is always a plus.
As always, I want to remind everyone to research before investing in the cannabis sector. Many risks are associated with investing in these companies, such as government regulations, lack of disclosure, etc. Only invest what you can afford to lose.
